Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects

NCT02055976 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: Bococizumab (PF-04950615;RN316)
DRUG: Bococizumab (PF-04950615;RN316)
DRUG: Bococizumab (PF-04950615;RN316)
DRUG: Placebo
DRUG: Ezetimibe
DRUG: Bococizumab (PF-04950615;RN316)
DRUG: Bococizumab (PF-04950615;RN316)
DRUG: Bococizumab (PF-04950615;RN316)
DRUG: Placebo

Sponsor

Pfizer